| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/31/2007 | US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 07/31/2007 | US7250431 neuropeptide Y(NPY) receptor antagonists; useful in the treatment of obesity; such as 4-methoxy-N-{4-[5-(2-methyl-benzoyl)-thiazol-2-ylamino]-phenyl}-benzenesulfonamide |
| 07/31/2007 | US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | US7250173 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2191645C Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |
| 07/26/2007 | WO2007084591A2 Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid |
| 07/26/2007 | WO2007084059A1 A food composition comprising amino acids |
| 07/26/2007 | WO2007083821A1 Anti-overstrain composition |
| 07/26/2007 | WO2007083119A2 Methods |
| 07/26/2007 | WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | WO2007082712A1 Long-acting colloidal formulation of insulin and preparation thereof |
| 07/26/2007 | WO2007082470A1 Pyrrolo-pyridazine derivatives,their preparation methods and uses |
| 07/26/2007 | WO2007082381A1 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders |
| 07/26/2007 | WO2007066355B1 Processes for the preparation and estimation of enriched calcitriol containing extracts from cestrum diurnum and compositions thereof |
| 07/26/2007 | WO2007062999A3 1,5-substituted indol-2-yl amide derivatives |
| 07/26/2007 | WO2007062175A3 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 07/26/2007 | WO2007008541A3 Cellular cholesterol absorption modifiers |
| 07/26/2007 | WO2006065706A9 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173525 Receptor or non-receptor types; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, agents; retinal vascularization |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173486 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent; antidepressant; eating disorders, obesity, nicotine addiction, neuropathy, cognitive disorders, attention deficit disorder, stress, epilepsy, dementia, distonia, Alzheimer's |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
| 07/26/2007 | CA2637838A1 Novel solid forms of (4r)-1-¬4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl|-1,2,3,5-tetrahydro-spiro¬4h-1-benzazepine-4,1'-¬2|cyclopentene|-3'-carboxylic acid |
| 07/26/2007 | CA2637449A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1810971A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 07/25/2007 | EP1810969A1 Aryloxy-substituted benzimidazole derivatives |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1810693A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/25/2007 | EP1810689A1 Preventive and/or therapeutic agent for diabetes |
| 07/25/2007 | EP1810677A1 Receptor function regulating agent |
| 07/25/2007 | EP1809674A1 Process for producing natural immunobiotic extract and uses thereof |
| 07/25/2007 | EP1809650A2 Polymorphs of sarsapogenin |
| 07/25/2007 | EP1809632A2 Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors |
| 07/25/2007 | EP1809626A2 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 07/25/2007 | EP1809335A2 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 07/25/2007 | EP1809331A2 Transepithelial delivery of peptides with incretin hormone activities |
| 07/25/2007 | EP1809284A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/25/2007 | EP1809282A2 Thiadiazole compounds and methods of use |
| 07/25/2007 | EP1809278A2 Combinations of pkc activators and pkc inhibitors for for alzheimer's disease treatment and cognitive enhancement |
| 07/25/2007 | EP1809271A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 07/25/2007 | EP1809125A1 Nutrition containing fat blend |
| 07/25/2007 | EP1697306B1 Selective peroxisome proliferator activated receptor modulators |
| 07/25/2007 | EP1546732B1 Modulation of the synthesis of insulin |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1448562B1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1325000B1 A thiazolidinedione derivative and its use as antidiabetic |
| 07/25/2007 | EP1322289B1 Spray drying process of compositions containing fenofibrate |
| 07/25/2007 | EP1286686B1 E-selectin for treating or preventing stroke |
| 07/25/2007 | EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
| 07/25/2007 | CN1327898C Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/25/2007 | CN1327882C Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 07/25/2007 | CN1327881C Diabetes treating Chinese medicine |
| 07/25/2007 | CN1327879C Medicine for treating diabetes and its preparing method |
| 07/25/2007 | CN1327876C Chinese drugs compositions for treating diabetes and its complications |
| 07/25/2007 | CN1327840C Medicinal composition and its use in treatment of diabetes |
| 07/25/2007 | CN1327832C Sibuqumin hydrochloride drip pill |
| 07/25/2007 | CN101006095A 脂肪酶抑制剂 Lipase inhibitors |
| 07/25/2007 | CN101006091A Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 07/25/2007 | CN101006089A Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 07/25/2007 | CN101006083A Dpp-iv inhibitors |
| 07/25/2007 | CN101006066A Arylcycloakyl-substituted alkanoic acid derivatives and its preparation method and uses as drug |
| 07/25/2007 | CN101005877A Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/25/2007 | CN101005857A Polypeptide protracting tags |
| 07/25/2007 | CN101005855A Methods of treating CCR2 mediated diseases or disorders |
| 07/25/2007 | CN101005847A Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
| 07/25/2007 | CN101003775A Method for producing health protection tea wine of ampelopsis grossedentata, and product |
| 07/25/2007 | CN101003574A Recombined expression of peptide for lowering blood sugar in long acting, and application in medication for treating diabetes |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003558A Glycoside class compound of mango, preparation method, and application in area of medicine |
| 07/25/2007 | CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 07/25/2007 | CN101003500A Sodium sulfonate substitution compound in diphenyl heptane class, and preparation method, and application |
| 07/25/2007 | CN101003481A Preparing compound of phenols difluoro heptane category, and oxidation resistant applcation |
| 07/25/2007 | CN101002906A Compounding traditional Chinese medicine, and its use |
| 07/25/2007 | CN101002888A Compounding traditional Chinese medicine-Tangniaokang for treating diabetes |
| 07/25/2007 | CN101002885A Biological medicine for treating diabetes, and its preparing method |
| 07/25/2007 | CN101002863A Health-care medicated wine |
| 07/25/2007 | CN101002861A Products of processed rhizoma alismatis to teat and prevent hyperlipidemia |
| 07/25/2007 | CN101002843A Medicine composition used for treating cardiovascular and cerebrovascular diseases |
| 07/25/2007 | CN101002830A Health-care capsule |
| 07/25/2007 | CN101002825A Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 07/25/2007 | CN101002822A Novel use of rhodiola root, and method for extracting its extractive |
| 07/25/2007 | CN101002815A Medical use of burdock total lignanoid |
| 07/25/2007 | CN101002804A Pure natural preparations used as depressor and hypolipidemic, and preparing method thereof |
| 07/25/2007 | CN101002765A Compressed formed preparation |
| 07/25/2007 | CN101002760A Application of chlorogenic acid for preparing medicine to treat diabetes complications |
| 07/25/2007 | CN101002625A Beverage for relieving summer heat, and its preparing process |
| 07/25/2007 | CN101002615A Method for producing fat substitute by using pectin as substrate |